EVALUATION
51. The authorities are to evaluate the registered
information provided by industry for certain chemicals. This extends
the current regime for existing chemicals under which priority
lists are drawn up for evaluation after some data have been supplied
by industry. It also builds on the current regime for new chemicals
under which authorities already evaluate the "notification"
dossier submitted by industry.
52. The White Paper estimates (on page 16) that 80
per cent of the approximately 30,000 registered substances "would
only require registration", and limits evaluation to chemicals
where production has exceeded 100 tonnes per annum and, at lower
tonnages, to chemicals of concern.
53. The proposed system therefore places much reliance
on the preliminary risk assessment that industry is required to
provide at the time of registration, not all of which will be
evaluated by the authorities. There are some proposals for targeted
risk assessments which would be less extensive and more focused
than the comprehensive risk assessments currently required.
AUTHORISATION
54. Chemicals "that
give rise to very high concern" will be subject to authorisation,
ie all use is banned unless a particular use is authorised.
This is a reversal of the current arrangement under which marketing
and use of named chemicals is restricted or totally banned, implying
that, in the absence of a restriction, marketing and use can proceed.
Controversy surrounds the selection of chemicals of very high
concern (see fuller discussion in paragraphs 95-102).
55. The authorisation procedure will involve two
steps:
Step 1
· identification
of substances subject to authorisation
· setting
time limits after which unauthorised use is prohibited
· scope
of exemptions
· determining
whether authorisation is to be granted at Member State or Community
level
Step 2
· actual
authorisation of particular uses
56. Most decisions relating
to authorisation would be taken at Community level"generally"
by a Committee procedure[23],
according to paragraph 8.1 (page 25) of the White Paper;
this contrasts with the current arrangements under which each
restriction requires a Council and Parliament Directive. The only
decisions to be taken at national level concern the use of substances
not incorporated in traded products which may affect the workforce
or the local environment
.